What is A2 Milk
Cow’s milk is made up of about 88% water and 12% solids. These solids include about 5% lactose, close to 4% fat, 3% protein and less than 1% minerals.
About 80% of the proteins in milk are caseins which are important suppliers of amino acids, carbohydrates, and the essential elements of calcium and phosphorous. All of these are required by the body for healthy nutrition.
​
These caseins are further divided into two different types - A1 and A2 beta caseins. Milk containing A1 beta-caseins release a bio-active peptide (BCM-7) in the small intestine during digestion.
This is categorized as an opioid and has been observed to cause suppression of the body’s immune system, gastrointestinal bloating and indigestion, an increase in the incidence of Type-1 diabetes, and slows down brain functions. It also inhibits the absorption of calcium in the body.
​
"A1 milk is produced by European cow breeds like the Holstein cow distinguished by its mottled black and white patch pattern."
A1 milk is produced by European cow breeds like the Holstein cow distinguished by its mottled black and white patch pattern.
​
A2 beta-caseins are produced only by Zebu or Bos Indicus cows that are recognized by their signature hump. Indigenous Indian cow breeds like Milk & Meadows Gir cows exclusively produce milk containing A2 beta-caseins. None of the negative effects associated with A1 milk are observed by those who consume only A2 milk.
​
Historically, all milk produced by cows was A2 milk. Over time, a mutation occurred bringing about A1 milk. A2 milk is the milk that was exclusively consumed by people everywhere for thousands of years and our bodies are genetically predisposed to process and digest A2 milk for better nutritional absorption.
​
Further Reading:
You’re Drinking the Wrong Kind of Milk
And we’re not talking about soy or almond, either.
​
https://www.motherjones.com/environment/2014/03/a1-milk-a2-milk-america/
​
​
​
Comparative effects of A1 versus A2 beta-casein on gastrointestinal measures:
a blinded randomised cross-over pilot study